Familial case of hypogonadotropic hypogonadism as the CHARGE syndrome manifestation

CHARGE syndrome is a rare autosomal dominant disease caused by CHD7 gene mutations. Individuals with CHARGE display a wide spectrum of clinical features. It might be presented only as a delay puberty, which does not require any hormone replacement therapy to severe CHARGE phenotype, requiring a multidisciplinary therapeutic approach. Wild spectrum of clinical presentation can be seen even among the patients with identical mutation. Diagnosis might be suspected by a combination of major and minor clinical criteria of this disorder, but molecular genetic analysis is mandatory for final verification. Accurate diagnosis is essential to informing patients about all possible clinical features, reproductive status and choosing the correct treatment approach. The most common endocrine abnormality in patients with CHARGE syndrome is the disturbance in gonadotropins function ranged from delay puberty to persistent hypogonadotropic hypogonadism with different olfactory phenotypes, resulted by specific role of CHD7 in GnRH neuronal embryogenesis.

We describe a familial case of CHARGE syndrome with significant intrafamilial clinical heterogeneity due to CHD7 gene mutation.

1. Hale CL, Niederriter AN, Green GE, Martin DM. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria. Am J Med Genet Part A. 2016;170(2):344-354. doi: https://doi.org/10.1002/ajmg.a.37435

2. Chetty M, Roberts TS, Elmubarak M, et al. CHARGE syndrome: genetic aspects and dental challenges, a review and case presentation. Head Face Med. 2020;16(1):10. doi: https://doi.org/10.1186/s13005-020-00224-4

3. Pagon RA, Graham JM, Zonana J, Yong S-L. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99(2):223-227. doi: https://doi.org/10.1016/S0022-3476(81)80454-4

4. Verloes A. Updated diagnostic criteria for CHARGE syndrome: A proposal. Am J Med Genet Part A. 2005;133A (3):306-308. doi: https://doi.org/10.1002/ajmg.a.30559

5. Vissers LELM, van Ravenswaaij CMA, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36(9):955-957. doi: https://doi.org/10.1038/ng1407

6. Leviashvili JG, Savenkova ND, Gorkina OK, et al. CHARGE syndrome. Ross Vestn Perinatol i Pediatr (Russian Bull Perinatol Pediatr). 2020;65(1):116-121. doi: https://doi.org/10.21508/1027-4065-2020-65-1-116-121

7. Garbaruk ES, Nnomzoo AA, Pavlov PV, Gorkina OC. Algorithm of hearing monitoring of children with congenital heart disease. Pediatr (St Petersburg). 2019;10(2):129-135. doi: https://doi.org/10.17816/PED102129-135

8. Balasubramanian R, Crowley WF. Reproductive endocrine phenotypes relating to CHD7 mutations in humans. Am J Med Genet Part C Semin Med Genet. 2017;175(4):507-515. doi: https://doi.org/10.1002/ajmg.c.31585

9. Marcos S, Sarfati J, Leroy C, et al. The Prevalence of CHD7 Missense Versus Truncating Mutations Is Higher in Patients With Kallmann Syndrome Than in Typical CHARGE Patients. J Clin Endocrinol Metab. 2014;99(10): E2138-E2143. doi: https://doi.org/10.1210/jc.2014-2110

10. Basson MA, van Ravenswaaij-Arts C. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. Trends Genet. 2015;31(10):600-611. doi: https://doi.org/10.1016/j.tig.2015.05.009

11. Dijk DR, Bocca G, van Ravenswaaij-Arts CM. Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach. J Multidiscip Healthc. 2019; 12: 607-620. doi: https://doi.org/10.2147/JMDH.S175713

12. Moccia A, Srivastava A, Skidmore JM, et al. Genetic analysis of CHARGE syndrome identifies overlapping molecular biology. Genet Med. 2018;20(9):1022-1029. doi: https://doi.org/10.1038/gim.2017.233

13. Lee YL, Toh L, Yap F. Delayed puberty and anosmia in charge syndrome: A case report. J ASEAN Fed Endocr Soc. 2020;35(1):122-124. doi: https://doi.org/10.15605/jafes.035.01.21

14. Izumi Y, Suzuki E, Kanzaki S, et al. Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertil Steril. 2014;102(4):1130-1136. doi: https://doi.org/10.1016/j.fertnstert.2014.06.017